DC
ABMD

Deere & Company’s Abiomed Inc ABMD Stock Holding History

Deere & Company’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-7,597
Closed -$203K – 1079
2013
Q4 		$203K Buy
+7,597
New +$188K 0.01% 923

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deere & Company's ABMD Position: Q1 2014 in Review

Deere & Company sold out of Abiomed Inc (ABMD) in Q1 2014, closing a stake of 7,597 shares — an estimated $203K sold.

Deere & Company first reported a position in ABMD in Q4 2013 and held it in 1 quarter. The position peaked at $203K in Q4 2013. 137 funds tracked by Wall St. Rank hold ABMD as of Q1 2014.

  • Deere & Company reported no remaining Abiomed Inc position as of Q1 2014 after selling out during the quarter.
  • Deere & Company sold 7,597 Abiomed Inc shares in Q1 2014, an estimated $203K.
  • Deere & Company first reported a position in Abiomed Inc in Q4 2013 and held it in 1 quarter.
  • Deere & Company's Abiomed Inc position peaked at $203K in Q4 2013.
  • 137 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2014.

Based on Deere & Company's 13F filing for Q1 2014, filed 8 May 2014.